ASH-Frank Toohey Abstract Achievement Award for Myelodysplastic Syndromes Grant

Q: When is the deadline for ASH-Frank Toohey Abstract Achievement Award for Myelodysplastic Syndromes Grant?

The funder has not published a deadline for this grant.

American Society of Hematology Inc

Foundation Grants for Science Research

Funding Amount

Up to US $5,000

Deadline

Deadline not published

Grant Type

Foundation

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Geography

To be eligible for this award, you must apply the MDS content tag (located under Diseases/Myeloid Malignancies/Chronic Myeloid Malignancies) to your abstract.
Special consideration will be given to those abstracts that also apply the “elderly” content tag (located under Study Population/Human).

Overview

The ASH-Frank Toohey Abstract Achievement Award for Myelodysplastic Syndromes recognizes outstanding research in MDS by trainees. This prestigious award, offered by the American Society of Hematology, grants $4,000 and a $1,000 travel allowance for in-person presentation at the annual meeting. Eligible applicants must be first authors of the highest-scoring abstracts, with a focus on older populations. This initiative aims to promote research excellence and support emerging scientists in the field of hematology.

The ASH-Frank Toohey Abstract Achievement Award for Myelodysplastic Syndromes (MDS) is part of the ASH Abstract Achievement Award program. This annual award shall be granted to a trainee (undergraduate student, medical student, graduate student, resident physician, or post-doctoral (MD or PhD) fellow) who is the first author and presenter of the highest-scoring abstract submitted in the field of MDS, with a preference for highly rated abstracts relating to older populations, when available. The recipient shall receive a $4,000 award. Awardees also receive a $1,000 travel allowance for travel to the annual meeting* and complimentary registration to the current year’s ASH annual meeting.
Travel allowance is contingent on presenting in person at the annual meeting and is not applicable for virtual presentations.

Eligibility

To be eligible for this award, you must apply the MDS content tag (located under Diseases/Myeloid Malignancies/Chronic Myeloid Malignancies) to your abstract. Special consideration will be given to those abstracts that also apply the “elderly” content tag (located under Study Population/Human).